OCULAR IMPLANT WITH STIFFNESS QUALITIES, METHODS OF IMPLANTATION AND SYSTEM

• US 20110028983A1
• Filed: 10/05/2010
• Published: 02/03/2011
• Est. Priority Date: 01/28/2009
• Status: Active Grant

• Current Assignee: Alcon Incorporated
• Original Assignee: Transcend Medical Incorporated (Alcon Incorporated)
• Inventors: de Juan, Eugene JR., Silvestrini, Thomas A.
• Granted Patent: US 8,262,726 B2
• Time in Patent Office: Days
• US Class Current: 606/108
• CPC Class Codes: A61F 2210/0019 operated at only one temperature whilst inside or touching the human body, e.g. constrained in a non-operative shape during surgery, another temperature only occurring before the operation
• CPC Class Codes: A61F 9/00781 Apparatus for modifying intraocular pressure, e.g. for glaucoma treatment drainage implants in general A61M27/002

Abstract

Described herein are devices and methods for treating eye conditions. Described is an ocular implant including an elongate member having an internal lumen forming a flow pathway, at least one inflow port communicating with the flow pathway, and at least one outflow port communicating with the flow pathway. The elongate member is adapted to be positioned in the eye such that at least one inflow port communicates with the anterior chamber, at least one outflow port communicates with the suprachoroidal space to provide a fluid pathway between the anterior chamber and the suprachoroidal space when the elongate member is implanted in the eye. The elongate member has a wall material imparting a stiffness to the elongate member. The stiffness is selected such that after implantation the elongate member deforms eye tissue surrounding the suprachoroidal space forming a tented volume.

Claims

1. A method of implanting an ocular device into the eye, comprising:

forming an incision in the cornea of the eye;

loading onto a delivery device an implant having a fluid passageway and a wall material imparting a stiffness to the implant;

inserting the implant loaded on the delivery device through the incision into the anterior chamber of the eye;

passing the implant along a pathway from the anterior chamber through an iridocorneal angle of the eye and into the suprachoroidal space, wherein the iridocorneal angle of the eye comprises an iris root, a portion of a ciliary body, a scleral spur, and a portion of the cornea;

positioning at least a portion of the implant in the suprachoroidal space such that a first portion of the fluid passageway communicates with the anterior chamber and a second portion of the fluid passageway cantilevers off the portion of the ciliary body into the suprachoroidal space and communicates with the suprachoroidal space to provide a fluid passageway between the suprachoroidal space and the anterior chamber.

2. The method of claim 1, wherein passing the implant along a pathway from the anterior chamber through the iridocorneal angle comprises penetrating the iris root with the delivery device.

3. The method of claim 1, wherein passing the implant along a pathway from the anterior chamber through the iridocorneal angle comprises penetrating a tissue boundary between the scleral spur and the portion of the ciliary body.

4. The method of claim 3, wherein penetrating the tissue boundary comprises penetrating a fibrous tissue attachment between the scleral spur and the portion of the ciliary body.

5. The method of claim 4, wherein the fibrous tissue attachment provides for additional fixation of the implant and props up the implant in the suprachoroidal space.

6. The method of claim 1, wherein passing the implant along a pathway from the anterior chamber through an iridocorneal angle of the eye and into the suprachoroidal space comprises penetrating the scleral spur with the delivery device.

7. The method of claim 1, wherein passing the implant along a pathway from the anterior chamber through an iridocorneal angle of the eye and into the suprachoroidal space comprises creating a puncture in the portion of the ciliary body and inserting the implant through the puncture.

8. The method of claim 1, wherein a distal end of the delivery device has a shape that is sufficiently sharp to penetrate the scleral spur.

9. The method of claim 1, wherein a distal end of the delivery device has a shape that is sufficiently sharp to penetrate the iris root and the portion of the ciliary body and sufficiently blunt so as not to substantially penetrate the scleral spur.

10. The method of claim 1, wherein positioning at least a portion of the implant in the suprachoroidal space comprises creating a dissection plane by bluntly dissecting between a region of the ciliary body and a first region of a sclera.

11. The method of claim 10, wherein creating the dissection plane further comprises dissecting between a region of a choroid and a second region of the sclera.

12. The method of claim 1, wherein positioning at least a portion of the implant in the suprachoroidal space comprises following an inner curve of a region of a sclera using the delivery device to peel away a region of the ciliary body and a region of a choroid from the region of the sclera.

13. The method of claim 12, wherein the delivery device has a radius of curvature that corresponds to a radius of curvature of the inner curve.

14. The method of claim 1, wherein passing the implant along a pathway from the anterior chamber comprises advancing the delivery device to the iridocorneal angle on a same side of the anterior chamber as the incision.

15. The method of claim 1, wherein passing the implant along a pathway from the anterior chamber comprises advancing the delivery device to the iridocorneal angle on an opposite side of the anterior chamber as the incision.

16. The method of claim 1, wherein inserting the implant loaded on the delivery device through the incision comprises passing a distal end of the implant through the incision followed by a proximal end of the implant.

17. The method of claim 1, wherein the second portion of the fluid passageway extends through a supraciliary space into the suprachoroidal space.

18. The method of claim 1, wherein the first portion of the fluid passageway remains within the anterior chamber.

19. The method of claim 1, wherein the first portion of the fluid passageway sits atop the portion of the ciliary body.